Connection

ADAM VOGEL to Liver Neoplasms

This is a "connection" page, showing publications ADAM VOGEL has written about Liver Neoplasms.
Connection Strength

0.539
  1. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 10 01; 29(Suppl 4):iv238-iv255.
    View in: PubMed
    Score: 0.279
  2. Clinical characteristics and outcome of patients with combined hepatocellular-cholangiocarcinoma-a European multicenter cohort. ESMO Open. 2023 02; 8(1):100783.
    View in: PubMed
    Score: 0.094
  3. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO. Ann Oncol. 2020 03; 31(3):334-351.
    View in: PubMed
    Score: 0.076
  4. Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis. Aliment Pharmacol Ther. 2018 02; 47(4):516-525.
    View in: PubMed
    Score: 0.066
  5. Hepatectomy in children under total hepatic occlusion. Am Surg. 2003 Jun; 69(6):539-41.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.